2025
SJR Q1
JCR Q1 · 3,7
OA
ESCI
Journal detail
Journal of Psychedelic Studies
- Publisher
- Akademiai Kiado
- Country
- Hungary · Eastern Europe
- Type
- journal
- ISSN
-
25599283
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,646
- Quartile Q1
- H-Index 19
- Cites/doc 3,26
- Docs (3y) 80
- Cites (3y) 267
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,7
- 5Y JIF 4,6
- JCI 0,9
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Anthropology Q1
- Biological Psychiatry Q3
- Clinical Psychology Q2
- Health (social science) Q2
- Pharmacology (medical) Q2
- Psychiatry and Mental Health Q2
- Social Psychology Q2
Areas
- Medicine
- Neuroscience
- Psychology
- Social Sciences
WoS categories
- Pharmacology & Pharmacy | Psychiatry | Psychology, Multidisciplinary
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,646 | 3,7 | 4,6 | 0,9 | Q2 | 19 |
| 2024 | Q1 | Q2 | 0,54 | 2,2 | — | 0,67 | Q2 | 14 |
| 2023 | Q1 | Q2 | 0,503 | 2,2 | — | 0,88 | Q2 | 14 |
| 2022 | Q1 | — | 0,416 | 4,5 | — | 0,97 | Q2 | 14 |
| 2021 | Q3 | — | 0,19 | — | — | — | — | 14 |
| 2020 | — | — | — | — | — | — | — | 14 |
| 2019 | — | — | — | — | — | — | — | 14 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | ESCI | Q2 | Q2 | 120/356 |
| 2025 | PSYCHIATRY | ESCI | Q2 | Q2 | 81/293 |
| 2025 | PSYCHOLOGY, MULTIDISCIPLINARY | ESCI | Q1 | Q2 | 37/222 |
| 2024 | PHARMACOLOGY & PHARMACY | ESCI | Q3 | Q2 | 209/352 |
| 2024 | PSYCHIATRY | ESCI | Q3 | Q3 | 152/288 |
| 2024 | PSYCHOLOGY, MULTIDISCIPLINARY | ESCI | Q2 | Q2 | 71/223 |
| 2023 | PHARMACOLOGY & PHARMACY | ESCI | Q3 | Q2 | 204/354 |
| 2023 | PSYCHIATRY | ESCI | Q3 | Q2 | 141/279 |
| 2023 | PSYCHOLOGY, MULTIDISCIPLINARY | ESCI | Q2 | Q2 | 78/219 |
| 2022 | PHARMACOLOGY & PHARMACY | ESCI | — | Q2 | — |
| 2022 | PSYCHIATRY | ESCI | — | Q2 | — |
| 2022 | PSYCHOLOGY, MULTIDISCIPLINARY | ESCI | — | Q2 | — |